Micah Belew, PhD, is a member of the licensing team that is responsible for evaluating, managing, and commercializing inventions arising from Dana-Farber. He also manages business development efforts, deal structuring/license drafting/negotiations, and post-transactional alliances. Dr. Belew received his PhD from the University of Massachusetts Medical School, studying the genetics of axon regeneration, aging, and host-microbial metabolism; he received his MS from the University of California-Davis, studying the molecular physiology of exercise and nutritional adaptation, specializing in skeletal muscle fat metabolism.
